학술논문
WHEN SHOULD WE USE MARGINAL STRUCTURAL MODELS FOR DRUG STUDIES IN RHEUMATOLOGY? THE EXAMPLE OF CORTICOSTEROIDS AND INFECTIONS IN RHEUMATOID ARTHRITIS.
Document Type
Article
Source
Annals of the Rheumatic Diseases; 2023 Supplement, Vol. 82, p443-443, 1/3p
Subject
Language
ISSN
00034967